Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366885 · ClinicalTrials.gov registry record · Phase 2
Vitamin D to Prevent Autism in Newborn Siblings
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01366885 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 20 participants.
The verdict
NCT01366885, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether by administering vitamin D to mothers who already have at least one child with autism and who are pregnant, that the vitamin D will prevent the recurrence of autism in the newborn sibling.
Interventions
- DRUG Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-02 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366885
The ClinicalTrials.gov registry entry for NCT01366885 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT01366885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366885 about?
NCT01366885 is a clinical study titled "Vitamin D to Prevent Autism in Newborn Siblings". The purpose of this study is to determine whether by administering vitamin D to mothers who already have at least one child with autism and who are pregnant, that the vitamin D will prevent the recurrence of autism in the newborn sibling.
What is the current status of trial NCT01366885?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2008-02. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01366885?
The interventions under investigation include: Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01366885?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.